Investigational Drug Information for Magnesium gluconate
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Magnesium gluconate?
Magnesium gluconate is an investigational drug.
There have been 10 clinical trials for Magnesium gluconate.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 28th 2019.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Peripheral Nervous System Diseases, and Neurotoxicity Syndromes. The leading clinical trial sponsors are National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, and Children's Hospital Medical Center, Cincinnati.
There are eight hundred and fifteen US patents protecting this investigational drug and five international patents.
Summary for Magnesium gluconate
| US Patents | 815 |
| International Patents | 5,739 |
| US Patent Applications | 3,224 |
| WIPO Patent Applications | 1,361 |
| Japanese Patent Applications | 917 |
| Clinical Trial Progress | Phase 3 (2019-08-28) |
| Vendors | 37 |
Recent Clinical Trials for Magnesium gluconate
| Title | Sponsor | Phase |
|---|---|---|
| The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients. | Medical University of Lodz | Phase 4 |
| The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients. | Medical Universtity of Lodz | Phase 4 |
| Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA | Woman's | Phase 4 |
Clinical Trial Summary for Magnesium gluconate
Top disease conditions for Magnesium gluconate
Top clinical trial sponsors for Magnesium gluconate
US Patents for Magnesium gluconate
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Magnesium gluconate | See Plans and Pricing | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome | ANTECIP BIOVENTURES II LLC (New York, NY) | See Plans and Pricing |
| Magnesium gluconate | See Plans and Pricing | Dialysis formulation | GAMBRO LUNDIA AB (Lund, SE) | See Plans and Pricing |
| Magnesium gluconate | See Plans and Pricing | Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult | See Plans and Pricing | |
| Magnesium gluconate | See Plans and Pricing | Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome | ANTECIP BIOVENTURES II LLC (New York, NY) | See Plans and Pricing |
| Magnesium gluconate | See Plans and Pricing | Compositions for oral administration of zoledronic acid or related compounds for treating Paget's disease of bone | ANTECIP BIOVENTURES II LLC (New York, NY) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Magnesium gluconate
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Magnesium gluconate | Australia | AU2013262995 | 2032-05-14 | See Plans and Pricing |
| Magnesium gluconate | Australia | AU2014340649 | 2032-05-14 | See Plans and Pricing |
| Magnesium gluconate | Australia | AU2015267046 | 2032-05-14 | See Plans and Pricing |
| Magnesium gluconate | Australia | AU2016256701 | 2032-05-14 | See Plans and Pricing |
| Magnesium gluconate | Australia | AU2017200832 | 2032-05-14 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
